Imunon (IMNN US)

Analysis

Health Care • United States

IMUNON, Inc. operates as a clinical stage biotechnology company. The Company focuses on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON serves customers worldwide.

Refresh

Company Event • 27 Mar 2026 21:30 • Upcoming

Add To Calendar

Q4 2025

Company Event • 14 Nov 2025 00:00 • Latest

Q3 2025

Company Event • 05 Aug 2025 23:00

Q2 2025

Company Event • 12 Jun 2025 23:30

Life Sciences Investor Forum

Company Event • 11 Jun 2025 22:00 • Upcoming